Q1 EPS Forecast for Bath & Body Works Raised by Analyst

Bath & Body Works, Inc. (NYSE:BBWI - Free Report) - Stock analysts at Telsey Advisory Group increased their Q1 2026 earnings per share estimates for Bath & Body Works in a research report issued to clients and investors on Tuesday, May 20th. Telsey Advisory Group analyst D. Telsey now expects that the company will post earnings per share of $0.49 for the quarter, up from their prior forecast of $0.42. Telsey Advisory Group has a "Outperform" rating and a $43.00 price target on the stock. The consensus estimate for Bath & Body Works' current full-year earnings is $3.30 per share. Telsey Advisory Group also issued estimates for Bath & Body Works' Q4 2026 earnings at $2.21 EPS and FY2026 earnings at $3.60 EPS.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings results on Thursday, February 27th. The company reported $2.09 EPS for the quarter, topping the consensus estimate of $2.04 by $0.05. The company had revenue of $2.79 billion during the quarter, compared to analysts' expectations of $2.78 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%.

A number of other research firms also recently weighed in on BBWI. Raymond James cut their price target on Bath & Body Works from $46.00 to $37.00 and set an "outperform" rating on the stock in a research note on Thursday, April 17th. Barclays raised their target price on Bath & Body Works from $31.00 to $35.00 and gave the stock an "equal weight" rating in a report on Tuesday. The Goldman Sachs Group lowered their price target on Bath & Body Works from $49.00 to $42.00 and set a "buy" rating for the company in a research note on Tuesday, April 22nd. Wells Fargo & Company increased their price target on shares of Bath & Body Works from $40.00 to $44.00 and gave the company an "overweight" rating in a research report on Wednesday, May 14th. Finally, Cowen restated a "buy" rating on shares of Bath & Body Works in a report on Thursday, February 27th. Four research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $42.56.

Bath & Body Works Stock Performance

Shares of BBWI stock opened at $31.14 on Thursday. The firm's 50 day moving average price is $30.19 and its two-hundred day moving average price is $34.01. Bath & Body Works has a 52-week low of $24.96 and a 52-week high of $52.99. The stock has a market cap of $6.63 billion, a PE ratio of 7.60, a PEG ratio of 0.92 and a beta of 1.87.

Bath & Body Works Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 20th. Stockholders of record on Friday, June 6th will be given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 2.57%. The ex-dividend date is Friday, June 6th. Bath & Body Works's dividend payout ratio is 21.98%.

Bath & Body Works declared that its board has authorized a share buyback plan on Thursday, February 27th that authorizes the company to repurchase $500.00 million in shares. This repurchase authorization authorizes the company to purchase up to 6.4% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company's leadership believes its shares are undervalued.

Institutional Investors Weigh In On Bath & Body Works

Several institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. lifted its holdings in shares of Bath & Body Works by 0.7% in the fourth quarter. Vanguard Group Inc. now owns 28,199,787 shares of the company's stock valued at $1,093,306,000 after purchasing an additional 208,036 shares in the last quarter. T. Rowe Price Investment Management Inc. lifted its stake in Bath & Body Works by 7.6% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 11,016,767 shares of the company's stock valued at $334,029,000 after acquiring an additional 781,681 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its position in Bath & Body Works by 5.5% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 8,494,089 shares of the company's stock worth $329,317,000 after acquiring an additional 445,887 shares during the last quarter. Victory Capital Management Inc. boosted its position in Bath & Body Works by 14,732.0% during the 1st quarter. Victory Capital Management Inc. now owns 6,798,108 shares of the company's stock worth $206,119,000 after acquiring an additional 6,752,274 shares during the last quarter. Finally, Alliancebernstein L.P. grew its stake in shares of Bath & Body Works by 4.7% during the 1st quarter. Alliancebernstein L.P. now owns 5,422,058 shares of the company's stock worth $164,397,000 after acquiring an additional 243,611 shares in the last quarter. 95.14% of the stock is owned by institutional investors.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.